Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OrbusNeich Medical Group Holdings's quarterly market cap
increased
from Dec. 2024 (HK$3,065 Mil) to Jun. 2025 (HK$3,287 Mil) but then
declined
from Jun. 2025 (HK$3,287 Mil) to Dec. 2025 (HK$2,980 Mil).
OrbusNeich Medical Group Holdings's annual market cap
declined
from Dec. 2023 (HK$5,831 Mil) to Dec. 2024 (HK$3,065 Mil) and
declined
from Dec. 2024 (HK$3,065 Mil) to Dec. 2025 (HK$2,980 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. OrbusNeich Medical Group Holdings's Enterprise Value for Today is HK$1,651 Mil.
OrbusNeich Medical Group Holdings (HKSE:06929) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
OrbusNeich Medical Group Holdings Market Cap Related Terms
OrbusNeich Medical Group Holdings Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OrbusNeich Medical Group Holdings Market Cap Chart
HKSE:06929 vs ISRG, BDX, RMD: Market Cap Comparison
For the Medical Instruments & Supplies subindustry, OrbusNeich Medical Group Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OrbusNeich Medical Group Holdings Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, OrbusNeich Medical Group Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where OrbusNeich Medical Group Holdings's Market Cap falls into.
OrbusNeich Medical Group Holdings Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OrbusNeich Medical Group Holdings (HKSE:06929) has a Market Cap of HK$3,153 Mil as of Sep. 06, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on OrbusNeich Medical Group Holdings and its competitors. According to the industry distribution chart, OrbusNeich Medical Group Holdings ranks #303 out of 859 companies in the Medical Devices & Instruments industry, placing it in the top 35.3%.
Is OrbusNeich Medical Group Holdings' Market Cap too high?
OrbusNeich Medical Group Holdings' current Market Cap is HK$3,153 Mil. Based on the distribution chart, OrbusNeich Medical Group Holdings ranks #303 out of 859 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, OrbusNeich Medical Group Holdings has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does OrbusNeich Medical Group Holdings' Market Cap compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, OrbusNeich Medical Group Holdings ranks #303 out of 859 companies for Market Cap. This puts OrbusNeich Medical Group Holdings in the upper half of its industry. The industry median Market Cap is 124.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 124.95, based on 859 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on OrbusNeich Medical Group Holdings and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 124.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OrbusNeich Medical Group Holdings's current Market Cap is HK$3,153 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OrbusNeich Medical Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, OrbusNeich Medical Group Holdings (HKSE:06929) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$5.30, compared to a current price of HK$3.83 — trading 27.7% below its estimated fair value. The current Market Cap is HK$3,153 Mil. OrbusNeich Medical Group Holdings' overall GF Score™ is 95/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For OrbusNeich Medical Group Holdings (HKSE:06929), the current Market Cap is HK$3,153 Mil as of Sep. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OrbusNeich Medical Group Holdings (HKSE:06929) Overvalued in 2026?
Based on GuruFocus' analysis, OrbusNeich Medical Group Holdings stock appears to be undervalued.
The current stock price of HK$3.83 is trading 27.7% below its estimated GF Value™ of HK$5.30.
GuruFocus considers OrbusNeich Medical Group Holdings to be Modestly Undervalued.
Key valuation signals for HKSE:06929:
Market Cap: HK$3,153 Mil
GF Value™: HK$5.30 vs. price of HK$3.83 (27.7% below fair value)
No single metric tells the full story. See the HKSE:06929 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OrbusNeich Medical Group Holdings Ltd is an investment holding company. The Company principally engaged in the manufacturing, trading, sales and marketing of medical devices/instruments used for the treatment of coronary and peripheral vascular diseases. The group has only one operating segment. The company has presence in APAC, EMEA, Japan, United States, The PRC, and Others of which majority of revenue comes from APAC.
95GF Score
Get the complete analysis for HKSE:06929
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:06929 has been successfully added to your 
